Study Evaluating Telemonitoring and Experimentation in Telemedicine for the Improvement of Healthcare Pathways (ETAPES Program) Compared to Standard of Care in Patients With Chronic Respiratory Failure Receiving Non-invasive Home Ventilation

NCT ID: NCT04615078

Last Updated: 2023-06-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

56 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-01-18

Study Completion Date

2022-07-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The ETAPES Program, a French national Experimentation in Telemedicine for the Improvement of Healthcare Pathways, was launched in 2018 for 4 years. Its objectives were to provide a temporary public reimbursement for medical telemonitoring in order to determine the benefits for the patient and the impact on medical organization and healthcare costs. In particular, this program applies to patients suffering from hypercapnic chronic respiratory failure and requiring home non invasive ventilation (NIV). For these patients, the ETAPES program combines NIV telemonitoring and therapeutic education.

e-VENT study aims at evaluating the ETAPES program, implemented using the Chronic Care Connect™ telemonitoring solution, versus Standard of Care, on the effectiveness of home NIV, measured by average PtCO2, reflecting the level of nocturnal alveolar hypoventilation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A prospective randomized study with two arms.

The primary endpoint is the level of nocturnal alveolar hypoventilation, defined as the average PtCO2 in nocturnal capnography performed at 6th month.

Patients with hypercapnic chronic respiratory failure requiring home NIV (n=100).

Multi-center study conducted in France involving approximately 20 sites

Product under study: Chronic Care Connect Pneumology telemonitoring solution, combining:

* a technical solution for the transmission and analysis of ventilator data, with the generation of alerts by a CE-marked algorithm;
* an organizational solution relying on a nurse call center.

Study design:

* First visit: eligibility criteria confirmation; randomization to 2 groups:

* the "Telemonitoring" group will participate in the ETAPES experimentation, with remote monitoring of their ventilator data with generation of alerts to the nurse call center, medical action if requested, and therapeutic education.
* the "Standard of Care" group will receive standard medical follow-up, with transmission of their ventilator data without generation of alerts.
* Second visit (6th month): arterial blood gases, nocturnal capnography. Collection of medical events having occurred in the past 6 months.
* Third visit (12th month): for COPD patients only - Collection of medical events having occurred in the past 6 months.
* At the end of the study, the investigators will complete a qualitative questionnaire on their telemonitoring practice.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Respiratory Failure With Hypercapnia Chronic Obstructive Pulmonary Disease (COPD) Obesity Hypoventilation Syndrome (OHS)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

"Telemonitoring" group

Medical Telemonitoring in Non-Invasive Ventilation

Group Type EXPERIMENTAL

ETAPES Program

Intervention Type DEVICE

The Chronic Care Connect Pneumology is a remote medical monitoring solution, combining:

* A technical solution for the transmission and analysis of ventilator data, leading to alerts generated by an algorithm ;
* An organizational solution relying on a nurse call center.

"Standard of Care" group

Standard medical follow-up: standard home Non-Invasive Ventilation service, with transmission of their ventilator data without analysis leading to alerts

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ETAPES Program

The Chronic Care Connect Pneumology is a remote medical monitoring solution, combining:

* A technical solution for the transmission and analysis of ventilator data, leading to alerts generated by an algorithm ;
* An organizational solution relying on a nurse call center.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Chronic Care Connect Pneumology Solution

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient with chronic respiratory failure for whom treatment with home NIV was prescribed at inclusion or two months earlier, and whose service provider is ADEP Assistance, ADAIR Assistance, ARAIR Assistance or VitalAire,
* Patient who meets all eligibility criteria to participate in the ETAPES program, namely:

* Patient aged 18 and over;
* Patient receiving NIV as part of an indication recognized by the Société de Pneumologie de Langue Française and the Haute Autorité de Santé;
* Patient never before included in the ETAPES program for the remote medical monitoring of their chronic respiratory failure;
* Patient having agreed to participate in the ETAPES program with the Chronic Care Connect Pneumology solution operated by the service providers ADEP Assistance, ADAIR Assistance, ARAIR Assistance or VitalAire, in the event that they are randomized to the Remote Medical Monitoring group;
* Patient agreeing to the collection of data from their ventilator via remote transmission;
* Patient fitted with a ventilator compatible with the Chronic Care Connect Pneumology solution;
* Patient with health insurance cover;
* Patient who has signed the consent form for the study.

Exclusion Criteria

* Patient who has any of the non-eligibility criteria for the ETAPES program:

* Physical or mental inability to use all components of the remote medical monitoring project, as determined by the doctor wishing to include the patient in the remote medical monitoring project;
* Patient with cancer with a life expectancy of less than 12 months estimated by the pulmonologist;
* Patient with more than three COPD respiratory decompensations resulting in hospitalization within the previous 12 months;
* Patient with diagnosed neuromuscular disease;
* Estimated poor compliance or standard adherence to treatment according to the physician including the patient;
* Patient's refusal of treatment support;
* No permanent place of residence;
* Patient participating in another intervention research program.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Air Liquide Santé International

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Arnaud PRIGENT, MD

Role: PRINCIPAL_INVESTIGATOR

Groupe Médical de Pneumologie, Polyclinique Saint Laurent - 35706 - Rennes - France

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Hospitalier de Boulogne sur Mer

Boulogne-sur-Mer, , France

Site Status

Centre Hospitalier de Bligny

Briis-sous-Forges, , France

Site Status

Claude SCHMITZ, MD

Colmar, , France

Site Status

Hôpital Forcilles - Fondation Cognacq-Jay

Férolles-Attilly, , France

Site Status

François BUGHIN, MD - Clinique du Millénaire

Montpellier, , France

Site Status

Clinique FSEF Paris 16ème

Paris, , France

Site Status

Groupe Hospitalier Pitié Salpêtrière-Charles Foix

Paris, , France

Site Status

Groupe Médical de Pneumologie, Polyclinique Saint Laurent

Rennes, , France

Site Status

Centre Hospitalier Universitaire de Toulouse - Hôpital Larrey

Toulouse, , France

Site Status

Centre Hospitalier Universitaire de Tours - Hôpital Bretonneau

Tours, , France

Site Status

Pierre-Henri GUILLAUD, MD

Vienne, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Prigent A, Texereau JB, Schmitz C, Ropars C, Degreef JM, Teulier M, Darne C, Lavergne F, Pasche H, Morelot-Panzini C. Real-world telemonitoring and remote support for home non-invasive ventilation to improve therapy effectiveness: the exploratory, multicentre randomised eVENT study. Thorax. 2025 Sep 15;80(10):720-729. doi: 10.1136/thorax-2024-222033.

Reference Type DERIVED
PMID: 40169180 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020-A02150-39

Identifier Type: OTHER

Identifier Source: secondary_id

ALMED-20-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.